Am J Transplant, Volume 20, Suppl 3 Archives - Page 10 of 223 - ATC Abstracts

2020 American Transplant Congress
Mental Health of Unspecified Anonymous Living Kidney Donors after Donation
W. Zuidema¹, S. Ismail², J. Wetering van de¹, L. Raalten van², W. Weimar¹, E. Massey¹
¹Internal Medicine, Erasmus MC, Rotterdam, Netherlands, ²Psychiatry, Erasmus MC, Rotterdam, Netherlands
*Purpose: Aim: Anonymous living kidney donors donates to an unknown stranger. These donors undergo psychosocial assessment to minimize likelihood of psychological harm from donation. The…
2020 American Transplant Congress
Traveling For Transplant: A Comparison of Singly Listed, Multiply Listed, and Non-Citizen Non-Resident Liver Transplant Candidates
H. J. Braun¹, D. Amara¹, A. Shui¹, C. Huang¹, P. G. Stock¹, R. Hirose¹, F. L. Delmonico², N. L. Ascher¹
¹University of California, San Francisco, San Francisco, CA, ²Harvard Medical School, Boston, MA
*Purpose: Multiply listed (ML) and non-citizen non-resident (NCNR) patients comprise approximately 8% of the liver transplant (LT) waitlist (WL) and approximately 4% of LT recipients.…
2020 American Transplant Congress
Therapeutic Targeting of Bile Acid Metabolism Ameliorates Liver Ischemia/Reperfusion Injury
M. Ni¹, D. Jin², T. Lu², J. Zhang¹, R. Busuttil¹, J. Kupiec-Weglinski¹, J. Zhang², Y. Zhai¹
¹Dumont-UCLA Transplant Center, Los Angeles, CA, ²Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
*Purpose: Farnesoid X receptor (FXR) is the major nuclear receptor of bile acids, which is also involved in the regulation of innate immune responses. As…
2020 American Transplant Congress
Novel Role of Qa-1, a Murine Homolog of HLA-E, in Controlling Follicular Helper T Cells During Humoral Alloimmunity
J. Y. Choi¹, S. K. Eskandari¹, S. Cai¹, J. Assaker¹, I. Sulkaj¹, H. Allos¹, J. Alhaddad¹, P. Chu¹, H. Kim², H. I. Cantor², J. R. Azzi¹
¹Medicine, Brigham and Women's Hospital, Boston, MA, ²Immunology, Dana Farber Cancer Institute, Boston, MA
*Purpose: Antibody-mediated rejection (AMR) is a major challenge in prolonging allograft survival. Limited insight into the humoral alloimmunity hinders the development of therapeutic strategies. We…
2020 American Transplant Congress
Long-Term Allograft Survival via Donor MHC Chimerism Induced by Exosomes
B. Gonzalez Nolasco, X. Wang, M. Wang, A. Prunevieille, K. M. Lee, J. F. Markmann, G. Benichou
Surgery - Center for Transplantation Sciences, Massachusetts General Hospital & Harvard Medical School, Boston, MA
*Purpose: Allogeneic transplant tolerance has been achieved by inducing mixed hematopoietic chimerism via donor bone marrow transplantation. Tolerance mechanisms in this model involve the presentation…
2020 American Transplant Congress
Thymoglobulin for Induction Less is Clearly More!
N. Patel, P. Nicole
-, -, SC
*Purpose: The ideal total dose of anti-thymocyte globulin (ATG) is unknown in the African American (AA) kidney transplant population.The purpose of this study was to…
2020 American Transplant Congress
Effect of Therapeutic Plasma Exchange on Glomerular Filtration Rate in Patients with Acute Humoral Rejection
M. Maza Moreno, S. Hernandez-Estrada, J. Cano Cervantes, D. Maldonado Tapia, M. Alamilla Sanchez
Nephrology and Transplant Division, CMN 20 de Noviembre, Ciudad de Mexico, Mexico
*Purpose: AMR is the main risk factor for graft loss, especially after the first post transplant year. Up to 80% of patients achieve response with…
2020 American Transplant Congress
Time-Trend of Metabolic Risks in Living Kidney Donors in South Korea
E. Kang¹, J. Park¹, S. Park¹, Y. Kim², J. Jeong³, J. An⁴, S. Lee⁵, S. Kim⁶, J. Cho⁷, M. Han⁸, H. Lee¹
¹Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, ²Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Korea, Republic of, ³Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of, ⁴Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea, Republic of, ⁵Internal Medicine, Chonbuk National University Hospital, Jeonju, Korea, Republic of, ⁶Internal Medicine, Chonnam National University Hospital, Gwangju, Korea, Republic of, ⁷Internal Medicine, Kyungpook National University, Seoul, Korea, Republic of, ⁸Internal Medicine, Pusan National University Hospital, Pusan, Korea, Republic of
*Purpose: Considering westernized lifestyles and increasing prevalence of chronic diseases occurred in Korea, time-trend exploration of metabolic risk in live kidney donors may help to…
2020 American Transplant Congress
Hepatitis C-Infected Donors and Hepatitis C-Infected Recipients: Analysis of Renal Transplant Outcomes
H. Crossman¹, M. Tavakol², C. Freise², P. Chin-Hong³
¹Internal Medicine Residency Program, UCSF, San Francisco, CA, ²Surgery, UCSF, San Francisco, CA, ³Infectious Disease, UCSF, San Francisco, CA
*Purpose: Increased utilization of hepatitis C virus infected organs could reduce the supply demand mismatch in organ transplantation. At this time, there is little data…
2020 American Transplant Congress
Malignancy Incidence after Pediatric Kidney Transplantation; a Single-Center Experience in Japan
Y. Aoki¹, H. Satoh¹, R. Hamada², R. Harada², M. Muramatsu³, Y. Hamasaki³, S. Shishido³
¹Urology and Kidney Transplantation, Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan, ²Nephrology, Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan, ³Nephrology, Toho University, Faculty of Medicine, Tokyo, Japan
*Purpose: The incidence of malignancy was higher in organ transplant recipients than in the general population, and malignancies are a well-recognized complication of organ transplantation.…